Philippe Chambon

Philippe Chambon

Vorstandsvorsitzender bei EG 427

65 Jahre
Health Technology
Technology Services
Commercial Services

Profil

Philippe O.
Chambon
founded New Leaf Venture Partners LLC in 2005, where he worked as Managing Director from 2005 to 2018.
Dr. Chambon also founded EG 427, where he is working as Chairman & Chief Executive Officer.
Dr. Chambon also currently works at BioRelix, Inc., as Director from 2009, Qpid Health, Inc., as Director from 2014, Phylos, Inc., as Director, FeetMe SAS, as Director, Stilla Technologies SA, as Director from 2018, Novadiscovery SAS, as Director, and LBO France Gestion SAS, as Venture Partner from 2018.
Dr. Chambon also formerly worked at NxStage Medical, Inc., as Chairman from 1998 to 2013, Transcend Therapeutics, Inc., as Director, Nuvelo, Inc., as Director, Pharsight Corp., as Director in 2007, Kalypsys, Inc., as Director, Auxilium Pharmaceuticals LLC, as Director from 2003 to 2011, Epocrates LLC, as Independent Director from 2011 to 2013, Aureon Biosciences, Inc., as Director, Truveris, Inc., as Director, Principia Biopharma, Inc., as Director, Spotfire, Inc., as Director, VaxInnate Corp., as Director, Artisan Pharma, Inc., as Director, Sandoz Pharmaceuticals Corp., as Executive Director-New Product Management in 1993, Pharnext SA, as Independent Non-Executive Director in 2018, Karos Pharmaceuticals, Inc., as Director, Treato Ltd., as Director, Tribun Healthcare SAS, as Director, Sprout Group, as General Partner from 1995 to 2004, and The Boston Consulting Group, Inc., as Manager-Healthcare Practice from 1993 to 1995.
Dr. Chambon received his Masters Business Admin degree from The Trustees of Columbia University in The City of New York and doctorate degree from Université Paris 1 Panthéon-Sorbonne.

Aktive Positionen von Philippe Chambon

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 16.04.2009
Direktor/Vorstandsmitglied 06.05.2014
Direktor/Vorstandsmitglied -
Private Equity Investor 01.02.2018
Direktor/Vorstandsmitglied 25.11.2018
Direktor/Vorstandsmitglied -
Vorstandsvorsitzender -
Direktor/Vorstandsmitglied -
Alle aktiven Positionen von Philippe Chambon

Ehemalige bekannte Positionen von Philippe Chambon

UnternehmenPositionEnde
Gründer 31.12.2018
░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Philippe Chambon im Detail an

Ausbildung von Philippe Chambon

The Trustees of Columbia University in The City of New York Masters Business Admin
Université Paris 1 Panthéon-Sorbonne Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Philippe Chambon im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
PHARNEXT SCA

Health Technology

Private Unternehmen28

Health Technology

Nuvelo, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Technology Services

Finance

Finance

Commercial Services

Commercial Services

Health Technology

Technology Services

Finance

Health Technology

Health Services

Sandoz Pharmaceuticals Corp.

Health Technology

Technology Services

Electronic Technology

Commercial Services

Technology Services

Technology Services

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Philippe Chambon